|
Valoración de DCF de FEMASYS Inc. (Femy)
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Femasys Inc. (FEMY) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de FEMASYS Inc. (Femy)! Obtenga datos financieros reales para las mujeres, ajuste las proyecciones y gastos de crecimiento, y observe instantáneamente cómo estas modificaciones afectan el valor intrínseco de las fuseles Inc.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .9 | 1.0 | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 |
Revenue Growth, % | 0 | 11.72 | 13.66 | 2.25 | -11.13 | 4.12 | 4.12 | 4.12 | 4.12 | 4.12 |
EBITDA | -10.2 | -5.8 | -6.6 | -10.5 | -13.2 | -1.1 | -1.2 | -1.2 | -1.3 | -1.3 |
EBITDA, % | -1094.04 | -558.8 | -555.26 | -869.27 | -1228.52 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 1.1 | 1.1 | 1.0 | .9 | .9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 |
Depreciation, % | 117.82 | 106.06 | 81.74 | 73.71 | 84.7 | 88.03 | 88.03 | 88.03 | 88.03 | 88.03 |
EBIT | -11.3 | -6.9 | -7.5 | -11.4 | -14.1 | -1.1 | -1.2 | -1.2 | -1.3 | -1.3 |
EBIT, % | -1211.86 | -664.85 | -637 | -942.98 | -1313.23 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 7.4 | 3.3 | 24.8 | 13.0 | 21.7 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 |
Account Receivables, % | 8.99 | 12.12 | 7.14 | 6.42 | 9.23 | 8.78 | 8.78 | 8.78 | 8.78 | 8.78 |
Inventories | .2 | .1 | .2 | .4 | .7 | .3 | .3 | .4 | .4 | .4 |
Inventories, % | 18.57 | 12.66 | 17.65 | 36.21 | 62.23 | 29.46 | 29.46 | 29.46 | 29.46 | 29.46 |
Accounts Payable | .5 | .7 | .4 | .5 | 1.1 | .7 | .7 | .7 | .7 | .8 |
Accounts Payable, % | 51.78 | 64.97 | 37.77 | 42.34 | 106.14 | 59.37 | 59.37 | 59.37 | 59.37 | 59.37 |
Capital Expenditure | -.7 | .0 | -.3 | -.4 | -.1 | -.3 | -.4 | -.4 | -.4 | -.4 |
Capital Expenditure, % | -74.97 | -3.05 | -26.01 | -33.78 | -13.43 | -30.25 | -30.25 | -30.25 | -30.25 | -30.25 |
Tax Rate, % | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 | -0.03045752 |
EBITAT | -11.3 | -6.9 | -7.5 | -11.4 | -14.1 | -1.1 | -1.2 | -1.2 | -1.3 | -1.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -10.6 | -5.6 | -7.1 | -11.1 | -12.9 | -.6 | -.5 | -.5 | -.5 | -.5 |
WACC, % | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 | 5.13 |
PV UFCF | ||||||||||
SUM PV UFCF | -2.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -1 | |||||||||
Terminal Value | -18 | |||||||||
Present Terminal Value | -14 | |||||||||
Enterprise Value | -16 | |||||||||
Net Debt | -15 | |||||||||
Equity Value | -1 | |||||||||
Diluted Shares Outstanding, MM | 15 | |||||||||
Equity Value Per Share | -0.07 |
What You Will Get
- Comprehensive FEMY Financials: Access to historical and projected data for informed valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are automatically computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Femasys Inc.'s future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data: Femasys Inc.’s (FEMY) historical financial records and pre-populated forecasts.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: View Femasys Inc.’s (FEMY) intrinsic value update instantly.
- Intuitive Visuals: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- 1. Open the Template: Download and access the Excel file containing Femasys Inc.'s [FEMY] preloaded data.
- 2. Edit Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV for [FEMY].
- 4. Test Scenarios: Analyze various forecasts to evaluate different valuation outcomes for Femasys Inc.
- 5. Use with Confidence: Present expert valuation insights to bolster your decision-making for [FEMY].
Why Choose the Femasys Inc. Calculator?
- Accuracy: Utilizes real Femasys financial data for precise calculations.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the need to create a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and attention to detail expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users with varying levels of financial knowledge.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing Femasys Inc. (FEMY) investment opportunities.
- Medical Device Companies: Assess valuation scenarios to inform strategic decisions within the industry.
- Financial Advisors: Offer clients precise valuation insights for Femasys Inc. (FEMY) stock.
- Students and Educators: Utilize current market data to enhance learning in financial modeling related to healthcare.
- Industry Analysts: Gain insights into how companies like Femasys Inc. (FEMY) are valued in the healthcare market.
What the Template Contains
- Pre-Filled Data: Includes Femasys Inc.'s historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Femasys Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.